In a similar approach, citrate-coated nanogolds were conjugated with the recombinant human TRAIL protein to develop nanogold-TRAIL complexes, which promote death receptor activation in M2 and tumor-associated macrophages (TAMs), displaying anti-inflammatory and pro-tumorigenic activity. The gene discussed is TNFSF10; the disease is neoplasm.